Protein C News and Research

RSS

SARS-CoV-2 breakthrough infection induces virus-specific nasal T-cells

A new study reports that hybrid immunity induced by vaccination and previous infection induces SARS-CoV-2-specific tissue-resident T-cells in the nasal cavity.

22 Aug 2022

“Drug factory” implants show promise in eradicating mesothelioma tumors

Rice University and Baylor College of Medicine researchers have shown they can eradicate advanced-stage mesothelioma tumors in mice in just a few days with a treatment combining Rice's cytokine "drug factory" implants and a checkpoint inhibitor drug.

22 Aug 2022

Researchers discover how patients with mutations in a DNA sequence develop pancreatic malformations

Researchers at the Centre for Genomic Regulation have identified a DNA sequence that is crucial for pancreatic differentiation and function – and for the first time – describe how it works.

22 Aug 2022

Scientists discover a mechanism used by insects in the development and regeneration of wings

The first mutation of the wingless gene was found by accident in Drosophila in the 1970s, following the observation of flies that did not possess wings, hence its name.

22 Aug 2022

New combination therapy shows potential to improve survival in children with neuroblastoma

Children who suffer a relapse of the aggressive cancer known as neuroblastoma have small chances of survival.

22 Aug 2022

Discovery of a group of latent stem cells could offer a new approach to treat brain and spinal cord injuries

Scientists at the Francis Crick Institute have identified a group of latent stem cells that respond to injury in the central nervous system of mice. If a similar type of cell exists in humans, they could offer a new therapeutic approach to treat brain and spinal cord injuries.

22 Aug 2022

Researchers reveal details of two key transition points in the development of pancreatic tumors

Pancreatic cancer has few treatment options and limited survival, with only 9% of patients still living five years after diagnosis.

22 Aug 2022

How effective are nanotechnology-based vaccines, drugs, and antibodies to combat variants of SARS-CoV-2?

Researchers explored how effectively nanotechnology-based novel and potential vaccines, drugs, and monoclonal antibodies could combat the current and yet to emerge SARS-CoV-2 variants.

22 Aug 2022

Scientists begin phase 2 clinical trials of lupus pill

Lupus is an autoimmune disease that attacks organs and can be fatal. There's no cure, so current treatments aim to limit damage and ameliorate symptoms.

22 Aug 2022

The effectiveness of three repurposed drugs in preventing serious SARS-CoV-2 infection in non-hospitalized adults

Researchers conducted a phase III clinical trial to test the effectiveness of three repurposed drugs - metformin, ivermectin, and fluvoxamine, in preventing progression to severe COVID-19.

22 Aug 2022

Durability of immune protection after booster immunization with COVID-19 adjuvanted subunit vaccine against the immune-evasive Omicron BA.1 variant

Researchers explored the durability of immunity imparted by the SARS-CoV-2 adjuvanted subunit vaccine against the Omicron variant.

22 Aug 2022

How natural alterations inside the SARS-CoV-2 glycan barrier affect spike protein dynamics

Researchers explored how the natural alterations inside the SARS-CoV-2 glycan barrier affect the spike protein dynamics.

22 Aug 2022

Consumption of ultra-processed foods increases risk of COVID-19

Researchers explore the association between consumption of ultra-processed foods and risk of SARS-CoV-2 infection.

21 Aug 2022

New discovery helps explain the dynamics underlying liver damage in type 2 diabetes and obesity

When fat accumulates in the liver, the immune system may assault the organ. A new study from Weill Cornell Medicine researchers identifies the molecule that trips these defenses, a discovery that helps to explain the dynamics underlying liver damage that can accompany type 2 diabetes and obesity.

19 Aug 2022

Cedars-Sinai investigators propose a theory for the cause of post-COVID syndromes

Investigators at Cedars-Sinai have proposed a theory for how SARS-CoV-2, the virus that causes COVID-19, infects the body. Their hypothesis, published in Frontiers in Immunology, could explain why some people still have symptoms long after the initial infection.

19 Aug 2022

Protein C News and Research

SARS-CoV-2 breakthrough infection induces virus-specific nasal T-cells

“Drug factory” implants show promise in eradicating mesothelioma tumors

Researchers discover how patients with mutations in a DNA sequence develop pancreatic malformations

Scientists discover a mechanism used by insects in the development and regeneration of wings

New combination therapy shows potential to improve survival in children with neuroblastoma

Discovery of a group of latent stem cells could offer a new approach to treat brain and spinal cord injuries

Researchers reveal details of two key transition points in the development of pancreatic tumors

How effective are nanotechnology-based vaccines, drugs, and antibodies to combat variants of SARS-CoV-2?

Scientists begin phase 2 clinical trials of lupus pill

The effectiveness of three repurposed drugs in preventing serious SARS-CoV-2 infection in non-hospitalized adults

Durability of immune protection after booster immunization with COVID-19 adjuvanted subunit vaccine against the immune-evasive Omicron BA.1 variant

How natural alterations inside the SARS-CoV-2 glycan barrier affect spike protein dynamics

Consumption of ultra-processed foods increases risk of COVID-19

New discovery helps explain the dynamics underlying liver damage in type 2 diabetes and obesity

Cedars-Sinai investigators propose a theory for the cause of post-COVID syndromes

Day-of-injury blood tests predict which TBI patients are likely to die or survive with severe disability

SARS-CoV-2 mRNA vaccination reveals HIV hiding in immune cells

SARS-CoV-2 variant neutralization and novel mAbs reveal protection against Omicron in new research

Researchers provide comprehensive review of human monkeypox infections

Johns Hopkins Medicine researchers challenge the prevailing belief on how nasal cells process scent

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News